ARCHIVES

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

This article is from The Cancer Letter archive.

Vol. 29 No. | August 12, 2003

Download PDF Visit The Full Archive

Related Articles

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987

NCA Approves Major Revision In Program Project Guidelines; Smaller, Tightly Focused Grants Seen

May 27, 1983

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

August 26, 2005

Kansas Gov. Sebelius Nominated For HHS

March 6, 2009

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001